Cargando…
System biology approaches identified novel biomarkers and their signaling pathways involved in renal cell carcinoma with different human diseases
Renal cell carcinoma (RCC) is a type of cancer that develops in the renal epithelium of the kidney. It is responsible for approximately 3% of adult malignancies, and 90–95% of neoplasms originate from the kidney. Advances in tumor diagnosis, innovative immune therapeutics, and checkpoint inhibitors-...
Autores principales: | Hossen, Md. Saddam, Samad, Abdus, Ahammad, Foysal, Sasa, Gabriel B.K., Jiang, Zhenggang, Ding, Xianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679400/ https://www.ncbi.nlm.nih.gov/pubmed/36314741 http://dx.doi.org/10.1042/BSR20221108 |
Ejemplares similares
-
HN1 as a diagnostic and prognostic biomarker for liver cancer
por: Liu, Zhicheng, et al.
Publicado: (2020) -
Circulating biomarkers associated with placental dysfunction and their utility for predicting fetal growth restriction
por: Hong, Jesrine, et al.
Publicado: (2023) -
BCL11A: a potential diagnostic biomarker and therapeutic target in human diseases
por: Yin, Jiawei, et al.
Publicado: (2019) -
Value of the cell cycle arrest biomarkers in the diagnosis of pregnancy-related acute kidney injury
por: El Minshawy, Osama, et al.
Publicado: (2021) -
Histomorphological and ultrastructural cadmium-induced kidney injuries and precancerous lesions in rats and screening for biomarkers
por: Wan, Xichen, et al.
Publicado: (2022)